FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039536698> ?p ?o ?g. }

• W2039536698 endingPage "48" @default.
• W2039536698 startingPage "40" @default.
• W2039536698 abstract "Circadian pattern for the onset of acute ischemic stroke has been described; however, data assessing an association between thrombolytic therapy efficacy and circadian rhythm are limited. We assessed the relationship between the time of stroke onset and neurologic outcomes after thrombolytic therapy for acute ischemic stroke in the National Institute of Neurological Disorders and Stroke (NINDS) Recombinant Tissue Plasminogen Activator (rt-PA) Stroke Trial.We conducted exploratory, post hoc analysis of 624 patients in the NINDS rt-PA Stroke Trial. Variables assessed included presenting time of day (4- and 6-hour time blocks), outcome variables, stroke subtypes, treatment assignment, and biological markers. Outcome variables included 3-month mortality, clinical outcome at 3 months, intracranial hemorrhage (ICH), computed tomography lesion volume at 3 months, and deterioration at 24 hours.The distribution of patients in the time blocks was balanced between the rt-PA and placebo groups. There was not a clear circadian variation in the stroke onset time. There were no associations detected between stroke onset time and clinical outcome, computed tomography lesion volume, and asymptomatic hemorrhage. Patients treated with rt-PA whose stroke onset was between 0401 and 0800 hours had less symptomatic ICH, whereas those who received rt-PA between 0000 and 0400 hours had a 43% incidence of symptomatic ICH. Patients in the placebo group who had stroke onset between 1801 and 2400 hours had lower chances for neurologic deterioration. Patients who had a stroke between 0001 and 0400 hours had the highest fibrinogen concentrations.We did not find a circadian pattern to time of day of stroke onset in the patients included in the NINDS rt-PA Stroke Trial. The effect of rt-PA treatment on favorable outcome was independent of time of day of stroke onset. Patients who received rt-PA between 4 and 8 am were less likely to develop symptomatic ICH." @default.
• W2039536698 created "2016-06-24" @default.
• W2039536698 creator A5011757795 @default.
• W2039536698 creator A5024969771 @default.
• W2039536698 creator A5033945043 @default.
• W2039536698 creator A5069352060 @default.
• W2039536698 creator A5071926199 @default.
• W2039536698 creator A5086474167 @default.
• W2039536698 date "2010-01-01" @default.
• W2039536698 modified "2023-10-07" @default.
• W2039536698 title "Time of Day, Outcome, and Response to Thrombolytic Therapy: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial Experience" @default.
• W2039536698 cites W1874700596 @default.
• W2039536698 cites W1964052017 @default.
• W2039536698 cites W1964070712 @default.
• W2039536698 cites W1969661146 @default.
• W2039536698 cites W1974689959 @default.
• W2039536698 cites W1974742589 @default.
• W2039536698 cites W1981517237 @default.
• W2039536698 cites W2001573193 @default.
• W2039536698 cites W2002140553 @default.
• W2039536698 cites W2015843467 @default.
• W2039536698 cites W2016823967 @default.
• W2039536698 cites W2024317926 @default.
• W2039536698 cites W2025211630 @default.
• W2039536698 cites W2038010542 @default.
• W2039536698 cites W2038410213 @default.
• W2039536698 cites W2041417677 @default.
• W2039536698 cites W2042859410 @default.
• W2039536698 cites W2051048785 @default.
• W2039536698 cites W2051801861 @default.
• W2039536698 cites W2075258924 @default.
• W2039536698 cites W2091483318 @default.
• W2039536698 cites W2107992838 @default.
• W2039536698 cites W2126348031 @default.
• W2039536698 cites W2129438116 @default.
• W2039536698 cites W2142253821 @default.
• W2039536698 cites W2145722221 @default.
• W2039536698 cites W2146362351 @default.
• W2039536698 cites W2148510598 @default.
• W2039536698 cites W2155758555 @default.
• W2039536698 cites W2167466867 @default.
• W2039536698 cites W2292308933 @default.
• W2039536698 cites W2313337474 @default.
• W2039536698 cites W2399826367 @default.
• W2039536698 cites W2419042299 @default.
• W2039536698 cites W4319718799 @default.
• W2039536698 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.03.006" @default.
• W2039536698 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20123226" @default.
• W2039536698 hasPublicationYear "2010" @default.
• W2039536698 type Work @default.
• W2039536698 sameAs 2039536698 @default.
• W2039536698 citedByCount "13" @default.
• W2039536698 countsByYear W20395366982012 @default.
• W2039536698 countsByYear W20395366982013 @default.
• W2039536698 countsByYear W20395366982014 @default.
• W2039536698 countsByYear W20395366982015 @default.
• W2039536698 countsByYear W20395366982018 @default.
• W2039536698 countsByYear W20395366982022 @default.
• W2039536698 countsByYear W20395366982023 @default.
• W2039536698 crossrefType "journal-article" @default.
• W2039536698 hasAuthorship W2039536698A5011757795 @default.
• W2039536698 hasAuthorship W2039536698A5024969771 @default.
• W2039536698 hasAuthorship W2039536698A5033945043 @default.
• W2039536698 hasAuthorship W2039536698A5069352060 @default.
• W2039536698 hasAuthorship W2039536698A5071926199 @default.
• W2039536698 hasAuthorship W2039536698A5086474167 @default.
• W2039536698 hasConcept C121446783 @default.
• W2039536698 hasConcept C126322002 @default.
• W2039536698 hasConcept C127413603 @default.
• W2039536698 hasConcept C141071460 @default.
• W2039536698 hasConcept C142724271 @default.
• W2039536698 hasConcept C164705383 @default.
• W2039536698 hasConcept C204787440 @default.
• W2039536698 hasConcept C27081682 @default.
• W2039536698 hasConcept C2776572282 @default.
• W2039536698 hasConcept C2777910003 @default.
• W2039536698 hasConcept C2779581417 @default.
• W2039536698 hasConcept C2780645631 @default.
• W2039536698 hasConcept C2909817843 @default.
• W2039536698 hasConcept C42219234 @default.
• W2039536698 hasConcept C500558357 @default.
• W2039536698 hasConcept C535046627 @default.
• W2039536698 hasConcept C71924100 @default.
• W2039536698 hasConcept C78519656 @default.
• W2039536698 hasConceptScore W2039536698C121446783 @default.
• W2039536698 hasConceptScore W2039536698C126322002 @default.
• W2039536698 hasConceptScore W2039536698C127413603 @default.
• W2039536698 hasConceptScore W2039536698C141071460 @default.
• W2039536698 hasConceptScore W2039536698C142724271 @default.
• W2039536698 hasConceptScore W2039536698C164705383 @default.
• W2039536698 hasConceptScore W2039536698C204787440 @default.
• W2039536698 hasConceptScore W2039536698C27081682 @default.
• W2039536698 hasConceptScore W2039536698C2776572282 @default.
• W2039536698 hasConceptScore W2039536698C2777910003 @default.
• W2039536698 hasConceptScore W2039536698C2779581417 @default.
• W2039536698 hasConceptScore W2039536698C2780645631 @default.
• W2039536698 hasConceptScore W2039536698C2909817843 @default.
• W2039536698 hasConceptScore W2039536698C42219234 @default.

• next